# HOPE Against Cancer Recurrence in HCC

> **NCT06717919** · PHASE4 · RECRUITING · sponsor: **Philipp Dutkowski** · enrollment: 220 (estimated)

## Conditions studied

- Liver Transplantation
- HCC
- Oncological Outcomes

## Interventions

- **PROCEDURE:** Hypothermic oxygenated perfusion
- **PROCEDURE:** Conventional cold storage

## Key facts

- **NCT ID:** NCT06717919
- **Lead sponsor:** Philipp Dutkowski
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06717919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06717919, "HOPE Against Cancer Recurrence in HCC". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06717919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*